Share Information
ViroGates A/S was listed on Nasdaq First North Denmark (VIRO) on 26 June 2018.
Below you will find information about the ViroGates share.
900+
published suPAR studies in leading medical journals
The suPARnostic® brand consists of 4 products:
suPAR is used in clinical routine in 48 hospitals
48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.
New Webinar